Financial results - ELPIS PHARM SRL

Financial Summary - Elpis Pharm Srl
Unique identification code: 5629053
Registration number: J1994000623020
Nace: 4100
Sales - Ron
25.340
Net Profit - Ron
-324
Employees
1
Open Account
Company Elpis Pharm Srl with Fiscal Code 5629053 recorded a turnover of 2024 of 25.340, with a net profit of -324 and having an average number of employees of 1. The company operates in the field of Lucrări de construcţii a clădirilor rezidenţiale şi nerezidenţiale having the NACE code 4100.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Elpis Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 90.354 24 0 849 21.393 1.396 680 0 0 25.340
Total Income - EUR 121.438 26 0 850 21.420 3.859 680 0 0 25.340
Total Expenses - EUR 122.527 1.183 3.998 5.403 37.614 9.123 605 28 503 25.664
Gross Profit/Loss - EUR -1.090 -1.157 -3.998 -4.553 -16.194 -5.265 74 -27 -503 -324
Net Profit/Loss - EUR -1.362 -1.157 -3.998 -4.578 -16.409 -5.380 54 -27 -503 -324
Employees 6 0 0 1 1 1 0 0 0 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Elpis Pharm Srl

Rating financiar

Financial Rating -
ELPIS PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Elpis Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Elpis Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Elpis Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Elpis Pharm Srl - CUI 5629053

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 0 11.506 8.143 4.894 0 0 0 0 0
Current Assets 43.810 41.972 40.352 39.150 13.478 12.480 12.057 12.067 10.517 16.320
Inventories 0 0 169 0 0 0 0 0 0 0
Receivables 36.128 34.434 33.953 35.225 12.008 10.660 10.456 10.488 10.457 10.550
Cash 7.681 7.539 6.230 3.925 1.470 1.821 1.601 1.578 60 5.771
Shareholders Funds 23.741 22.342 17.969 13.061 -3.601 -6.168 -5.978 -6.024 -6.508 -6.796
Social Capital 45 45 46 45 44 43 42 43 42 42
Debts 20.069 19.630 33.889 34.232 22.194 18.866 18.247 18.303 17.237 23.327
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4100 - 4100"
CAEN Financial Year 4520
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 16.320 euro in 2024 which includes Inventories of 0 euro, Receivables of 10.550 euro and cash availability of 5.771 euro.
The company's Equity was valued at -6.796 euro, while total Liabilities amounted to 23.327 euro. Equity decreased by -324 euro, from -6.508 euro in 2023, to -6.796 in 2024.

Risk Reports Prices

Reviews - Elpis Pharm Srl

Comments - Elpis Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.